• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

作者信息

Zoulim F, Trépo C

机构信息

Inserm Unit 271, Hôtel Dieu Hospital, Lyon, France.

出版信息

J Hepatol. 1998 Jul;29(1):151-68. doi: 10.1016/s0168-8278(98)80191-8.

DOI:10.1016/s0168-8278(98)80191-8
PMID:9696505
Abstract
摘要

相似文献

1
Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.慢性乙型肝炎的药物治疗：抗病毒疗效及乙型肝炎病毒聚合酶突变对治疗结果的影响
J Hepatol. 1998 Jul;29(1):151-68. doi: 10.1016/s0168-8278(98)80191-8.
2
[Efficacy and problems in combination therapy using lamivudine and interferon for chronic hepatitis B].[拉米夫定与干扰素联合治疗慢性乙型肝炎的疗效及问题]
Nihon Rinsho. 2004 Aug;62 Suppl 8:326-30.
3
Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.TDF-ETV 联合治疗中选择高度复制和部分多药耐药 rtS78T HBV 聚合酶突变。
J Hepatol. 2017 Aug;67(2):246-254. doi: 10.1016/j.jhep.2017.03.027. Epub 2017 Apr 7.
4
How to overcome antiviral-resistant hepatitis B virus?如何克服抗病毒耐药的乙型肝炎病毒？
Intervirology. 2010;53(1):29-38. doi: 10.1159/000252781. Epub 2010 Jan 5.
5
Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions.序列分析与INNO-LiPA HBV DR线性探针检测法在不同临床条件下患者中检测拉米夫定耐药乙型肝炎病毒株的比较。
J Clin Microbiol. 2001 May;39(5):1972-4. doi: 10.1128/JCM.39.5.1972-1974.2001.
6
Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B.与乙型肝炎抗病毒治疗相关的乙型肝炎病毒聚合酶基因突变。
J Viral Hepat. 1999 May;6(3):183-94. doi: 10.1046/j.1365-2893.1999.00160.x.
7
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.治疗初治慢性乙型肝炎患者中乙型肝炎病毒 DNA 聚合酶突变的流行率。
Aliment Pharmacol Ther. 2009 Dec 1;30(11-12):1150-8. doi: 10.1111/j.1365-2036.2009.04151.x. Epub 2009 Sep 24.
8
Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in japanese patients with chronic hepatitis B.日本慢性乙型肝炎患者中与拉米夫定治疗耐药相关的乙型肝炎病毒聚合酶氨基酸突变新模式
J Med Virol. 1999 Nov;59(3):270-6.
9
[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].[慢性乙型肝炎治疗中应对抗乙肝病毒类似物耐药的未来展望与策略]
Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S34-6.
10
[Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].[慢性乙型肝炎治疗中对抗病毒类似物耐药性的管理]
Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S5-8.

引用本文的文献

1
Higher pretherapy and significant decrease during the first 12 months of therapy in serum laminin levels may associate with hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with lamivudine.血清层粘连蛋白水平在治疗前较高，且在治疗的前 12 个月内显著下降，可能与拉米夫定治疗的慢性乙型肝炎患者乙型肝炎 e 抗原血清学转换有关。
Clin Exp Med. 2010 Dec;10(4):245-51. doi: 10.1007/s10238-010-0091-8. Epub 2010 Feb 5.
2
Natural history and clinical management of chronic hepatitis B virus infection in children.儿童乙型肝炎病毒感染的自然史和临床管理。
Hepatol Int. 2008 May;2(Supplement 1):28-36. doi: 10.1007/s12072-008-9050-9. Epub 2008 Mar 6.
3
Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method.
一种改进的反向斑点杂交法对乙型肝炎病毒基因组中YMDD基序变异进行快速准确的基因分型
J Clin Microbiol. 2005 Nov;43(11):5685-9. doi: 10.1128/JCM.43.11.5685-5689.2005.
4
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.在土拨鼠乙型肝炎病毒感染模型中，拉米夫定和恩曲他滨联合腺病毒介导的γ干扰素递送的效果。
Antimicrob Agents Chemother. 2004 Jul;48(7):2683-92. doi: 10.1128/AAC.48.7.2683-2692.2004.
5
A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.拉米夫定治疗慢性乙型肝炎病毒感染的初步效益-风险评估。
Drug Saf. 2002;25(7):497-510. doi: 10.2165/00002018-200225070-00004.
6
Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.阿德福韦对鸭乙型肝炎病毒感染的肝细胞在体内和体外的病毒DNA合成及共价闭合环状DNA形成的抑制作用。
Antimicrob Agents Chemother. 2002 Feb;46(2):425-33. doi: 10.1128/AAC.46.2.425-433.2002.
7
Tolerability of treatments for viral hepatitis.
Drug Saf. 2001;24(5):375-84. doi: 10.2165/00002018-200124050-00004.
8
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.β-L-2',3'-二脱氧-2',3'-二脱氢-5-氟胞苷对慢性感染土拨鼠肝炎病毒的土拨鼠的抗病毒活性。
Antimicrob Agents Chemother. 2001 Apr;45(4):1065-77. doi: 10.1128/AAC.45.4.1065-1077.2001.
9
Clinical potential of emerging new agents in hepatitis B.新型乙肝治疗药物的临床潜力
Drugs. 2000 Oct;60(4):701-10. doi: 10.2165/00003495-200060040-00001.
10
In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.喷昔洛韦、拉米夫定和阿德福韦联合用药的体外抗乙肝病毒活性
Antimicrob Agents Chemother. 2000 Mar;44(3):551-60. doi: 10.1128/AAC.44.3.551-560.2000.